Form 4 for HUMA Humacyte, Inc.
Accepted 2025-11-17 00:00:00 ET · period of report 2025-11-16 · accession 0001628280-25-052723 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-17 | 2025-11-16 | HUMA | Sander Dale A. | CFO, Chief Corp. Deve. Off | A - Grant | $0.00 | +311.1K | 313.1K | +15,555% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-16 | A | A | 311,100 | $0.00 | 313,100 | D | — | — | (F1) The Reporting Person was granted restricted stock units (RSUs), which represent a contingent right to receive one share of Common Stock for each RSU. The first 50% of the RSUs will vest on May 15, 2026, after which the remaining 50% of the RSUs will vest on May 15, 2027. |